» Articles » PMID: 11493462

Th2 Polarization by Der P 1--pulsed Monocyte-derived Dendritic Cells is Due to the Allergic Status of the Donors

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2001 Aug 9
PMID 11493462
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The polarization of the immune response toward a Th2 or a Th1 profile can be mediated by dendritic cells (DCs) following antigen presentation and interaction with T cells. Costimulatory molecules such as CD80 and CD86 expressed by DCs, the polarizing cytokine environment during DC--T-cell interaction, and also the nature of the antigen are critical in the orientation of the immune response. In this study, the effect of the cysteine protease Der p 1, one of the major allergens of the house dust mite Dermatophagoides pteronyssinus, on these different parameters was evaluated comparatively on monocyte-derived DCs obtained from healthy donors, from pollen-sensitive patients, or from patients sensitive to Dermatophagoides pteronyssinus. Results showed that Der p 1 induced an increase in CD86 expression only on DCs from house dust mite--sensitive patients. This was also associated with a higher capacity to induce T-cell proliferation, a rapid increase in the production of proinflammatory cytokines, tumor necrosis factor--alpha and interleukin (IL)-1 beta, and the type 2 cytokine IL-10. No changes in the release of IL-12 p70 were induced by Der p 1. Finally, purified T cells from house dust mite-sensitive patients stimulated by autologous Der p 1--pulsed DCs preferentially produced IL-4 rather than interferon-gamma. These effects were abolished in the presence of the inactive precursor of Der p 1 (ProDer p 1). Taken together, these data suggest that DCs from house dust mite--sensitive patients, in contrast to DCs from healthy donors and from pollen-sensitive patients, exposed to Der p 1 play a pivotal role in the enhancement of the Th2 response associated with the allergic reaction developed in response to house dust mite exposure. (Blood. 2001;98:1135-1141)

Citing Articles

Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases.

Nguyen H, Tiberio L, Facchinetti F, Ripari G, Violi V, Villetti G Pharmaceutics. 2023; 15(9).

PMID: 37765223 PMC: 10535230. DOI: 10.3390/pharmaceutics15092254.


Protease allergens as initiators-regulators of allergic inflammation.

Soh W, Zhang J, Hollenberg M, Vliagoftis H, Rothenberg M, Sokol C Allergy. 2023; 78(5):1148-1168.

PMID: 36794967 PMC: 10159943. DOI: 10.1111/all.15678.


Catching Our Breath: Updates on the Role of Dendritic Cell Subsets in Asthma.

Lajiness J, Cook-Mills J Adv Biol (Weinh). 2023; 7(6):e2200296.

PMID: 36755197 PMC: 10293089. DOI: 10.1002/adbi.202200296.


Mechanistic insights into silica nanoparticle-allergen interactions on antigen presenting cell function in the context of allergic reactions.

Johnson L, Aglas L, Punz B, Dang H, Christ C, Pointner L Nanoscale. 2023; 15(5):2262-2275.

PMID: 36630186 PMC: 9893438. DOI: 10.1039/d2nr05181h.


The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation.

Nguyen H, Salvi V, Tiberio L, Facchinetti F, Govoni M, Villetti G J Transl Med. 2022; 20(1):203.

PMID: 35538539 PMC: 9092691. DOI: 10.1186/s12967-022-03402-x.